首页   按字顺浏览 期刊浏览 卷期浏览 Recent Advances in Treatment of Acute Mania
Recent Advances in Treatment of Acute Mania

 

作者: JAMES,  

 

期刊: Journal of Clinical Psychopharmacology  (OVID Available online 1991)
卷期: Volume 11, issue 1  

页码: 3-21

 

ISSN:0271-0749

 

年代: 1991

 

出版商: OVID

 

数据来源: OVID

 

摘要:

Standard and more recent advances in treatment of acute mania are reviewed with special emphasis oncontrolledstudies. Lithium is still the drug of choice and the most common treatment for mania, but some of its limitations have become more apparent, and specific indications for its use are defined. Alternatives to lithium are recommended for psychotic, rapid cycling, severely manic, and lithium-refractory patients. Neuroleptics are effective and used commonly but carry risks of long term side effects. Substantial reduction in neuroleptic dose and duration of exposure is probably feasible in many patients. Neuroleptic-lithium combinations are popular but do not have clear advantages over treatment with a single drug in the initial treatment of acute mania. These combinations have also been associated with increased neurotoxicity. Carbamazepine, both alone and in combination with lithium, has been used increasingly over recent years. Its efficacy is comparable to lithium, but clinical features predicting responsiveness may be different for these two drugs. Carbamazepine-neuroleptic combinations offer little advantage over neuroleptics alone. Valproic acid, verapamil, clonazepam, lorazepam, benzodiazepine-neuroleptic combinations, clonidine, tryptophan, propranolol, and electroconvulsive therapy are also popular, but their effectiveness has not yet been adequately confirmed by controlled studies.

 

点击下载:  PDF (1708KB)



返 回